Sleep Disorders Trial, Recruiting NCT06482814 Sponsor: Mayo Clinic Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06482814
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 35 years old
  • People who are generally healthy, with no significant physical or mental health conditions (as decided by the study doctors)
  • Non-smokers
  • People who are not pregnant
  • People who normally sleep 7–9 hours per night and do not regularly take naps
  • People who know whether or not their biological mother and father have or had high blood pressure
  • People who are able to understand and follow all study procedures for the full length of the study
  • People who can understand English and agree to participate by signing a consent form

Who may not be able to join:

  • Anyone under 18 or over 35 years old
  • Anyone whose body weight falls outside a healthy range (BMI under 18.5 or 30 and above)
  • Anyone who is pregnant or breastfeeding
  • Anyone who does not know their biological parents' blood pressure history, or who was adopted
  • Anyone who uses tobacco, vaping products, marijuana, or other recreational drugs
  • Anyone who consumes more than 400 mg of caffeine per day (roughly more than 3–4 cups of coffee)
  • Anyone who drinks alcohol heavily — more than 7 drinks per week for women, or more than 14 drinks per week for men
  • Anyone with high blood pressure readings at the clinic or during a daytime blood pressure monitoring test
  • Anyone with high fasting blood sugar levels
  • Anyone with reduced kidney function (confirm with trial site)
  • Anyone with significant physical or mental health conditions (as decided by the study doctors)
  • Anyone regularly taking prescription medications, except for contraceptives (birth control)
  • Anyone using melatonin supplements or any other over-the-counter sleep aids
  • Anyone with moderate to severe sleep apnea, or mild sleep apnea combined with significant daytime sleepiness
  • Anyone with moderate to severe insomnia
  • Anyone with restless leg syndrome
  • Anyone with excessive daytime sleepiness
  • Anyone who is considered an extreme "morning person" or extreme "night owl" based on a sleep questionnaire (confirm with trial site)
  • Anyone who works night shifts
  • Anyone currently taking part in another research study (as decided by the study doctors)
  • Anyone for whom participating would be impractical for medical, location-based, or personal reasons
  • Anyone who cannot understand English or is unable to provide informed consent
  • Anyone with low hemoglobin (a measure of red blood cells in the blood) may not be able to take part in the blood draw portions of the study, but may still be able to participate in other parts (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Naima Covassin, Ph.D, Mayo Clinic

Phone: (507)255-0151

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
20 February 2025
Est. completion
1 April 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

24-hour Systolic Blood Pressure (BP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov